Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Thyroid Carcinoma, Anaplastic × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Paclitaxel 3 pembrolizumab 2 efatutazone 2 trametinib 1 tislelizumab 1 surufatinib 1 spartalizumab 1 sapanisertib 1 pazopanib 1 lenvatinib 1 fosbretabulin 1 dabrafenib 1 crolibulin 1 combretastatin 1 cabozantinib 1 atezolizumab 1 abemaciclib 1 Sorafenib 1 Radiotherapy, Intensity-Modulated 1 Imatinib Mesylate 1 Gefitinib 1 Doxorubicin 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 CUDC-907 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡